Emodin inhibits M1 macrophage activation that related to acute and chronic kidney injury through EGFR/MAPK pathway
Functional & Integrative Genomics · 2024
DOI: 10.1007/s10142-024-01407-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Functional & Integrative Genomics, 2024. Verfasst von Weijian Xiong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Chongqing Traditional Chinese Medicine Hospital, No.6 Panxi Road, Jiangbei District, Chongqing, 400021, China. Hauptthemen laut MEDLINE: Emodin, ErbB Receptors, Renal Insufficiency, Chronic, Macrophage Activation. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Chongqing Natural Science Foundation, Chongqing Municipal Health and Medical Joint Research Project, Special Project for Performance Incentives of Chongqing Research Institutions.
Abstract (Originalsprache)
BACKGROUND: Macrophages are the main inflammatory cells involved in kidney injury and play a significant role in the development of acute kidney injury (AKI) and progression of chronic kidney disease (CKD). Emodin is believed to stabilize macrophage homeostasis under pathological conditions. The objective of this study aimed to explore the underlying mechanisms and effects of Emodin on M1 macrophages. METHODS: Network pharmacology methods were used to predict target proteins associated with renal injury and identify the pathways affected by emodin. RAW264.7 macrophages were induced into M1 polarization using LPS and then treated with emodin at 20, 40, and 80 µM. The effects of emodin on cell viability, cytokines (IL-1β, IL-6, TNF-α), M1 macrophage markers (F4/80 + CD86+), and the EGFR/MAPK pathway were evaluated. Additionally, we transfected RAW264.7 cells with an EGFR shRNA interference lentivirus to assess its effects on RAW264.7 cells function and MAPK pathway. After RAW264.7 cells were passaged to expanded culture and transfected with EGFR-interfering plasmid, macrophages were induced to polarize towards M1 with LPS and then treated with 80 µM emodin. CKD modeling was performed to test how emodin is regulated during CKD. RESULTS: There are 15 common targets between emodin and kidney injury, of which the EGFR/MAPK pathway is the pathway through which emodin affects macrophage function. Emodin significantly reduced the levels of IL-6, IL-1β and TNF-α (p < 0.05) and the ratio of M1 macrophage surface markers F4/80 + CD86+ (p < 0.01) in the supernatant of RAW264.7 cells in a dose-dependent manner. Furthermore, the inhibitory effect of emodin on RAW264.7 cells was achieved by interfering with the EGFR/MAPK pathway. Moreover, emodin also affected the mRNA and protein expression of EGFR and Ras, leading to a decrease in the rate of M1 macrophages, thus inhibiting the pro-inflammatory effect of M1 macrophages. The addition of emodin reduced the rate of M1 macrophages in CKD and inhibited the further polarization of M1 macrophages, thus maintaining the pro-inflammatory and anti-inflammatory homeostasis in CKD, and these effects were achieved by emodin through the control of the EGRF/ERK pathway. CONCLUSION: Emodin attenuates M1 macrophage polarization and pro-inflammatory responses via the EGFR/MAPK signalling pathway. And the addition of emodin maintains pro- and anti-inflammatory homeostasis, which is important for maintaining organ function and tissue repair.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Chongqing Traditional Chinese Medicine Hospital, No.6 Panxi Road, Jiangbei District, Chongqing, 400021, China.
- Department of Nephrology, Chongqing Traditional Chinese Medicine Hospital, No.6 Panxi Road, Jiangbei District, Chongqing, 400021, China. sabrina_pipi@163.com.
Förderung
- Chongqing Natural Science Foundation
- Chongqing Municipal Health and Medical Joint Research Project
- Special Project for Performance Incentives of Chongqing Research Institutions
Zitieren
APA
Xiong, W., Tang, J., Yu, H., Luo, Y., Yu, M., & Li, Y. (2024). Emodin inhibits M1 macrophage activation that related to acute and chronic kidney injury through EGFR/MAPK pathway. Functional & Integrative Genomics. https://doi.org/10.1007/s10142-024-01407-x
Vancouver
Xiong W, Tang J, Yu H, Luo Y, Yu M, Li Y. Emodin inhibits M1 macrophage activation that related to acute and chronic kidney injury through EGFR/MAPK pathway. Functional & Integrative Genomics. 2024. doi:10.1007/s10142-024-01407-x
BibTeX
@article{Xiong2024,
author = {Xiong, Weijian and Tang, Jing and Yu, Hangxing and Luo, Yan and Yu, Minghuan and Li, Ying},
title = {Emodin inhibits M1 macrophage activation that related to acute and chronic kidney injury through EGFR/MAPK pathway},
journal = {Functional & Integrative Genomics},
year = {2024},
doi = {10.1007/s10142-024-01407-x}
}
EUVIMED